You have read all your free articles, to continue reading subscribe to read the rest of this content.
Oasmia Pharmaceutical AB has announced that it will launch their product Paclical in Russia and the Commonwealth of Independent States (CIS) countries. Oasmia Pharmaceutical, a developer of a new generation of drugs within human and veterinary oncology, has announced that it has shipped PaclicalAlready a subscriber Login You have read all…
Orion is planning to change and refocus the strategy of its R&D function and in the future focus would be on cancer and pain. Orion will initiate negotiations concerning in total 430 salaried employees and senior salaried employees in Finland in Espoo, Turku and Kuopio in the research areas iAlready…
Modus Therapeutics has announced that sevuparin for the treatment of SCD was granted rare pediatric disease designation by the US Food & Drug Administration (FDA). “We are very pleased with the FDA’s decision to grant a rare pediatric disease designation to sevuparin for SCD. The potentiAlready a subscriber Login You have…
The U.S. Food and Drug Administration has granted the designation for the company's vaccine candidate for active immunization for prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV) in adults aged 60 years or older. The designation has been granted upon the aAlready a subscriber Login You…
